COVID-19 therapeutics resources
Factsheets and resources and Medication guidelines for the treatment of COVID-19.
Date last updated: 12 Mar 2024
- ACI Guidance for the use of anti-SARS-CoV-2 monoclonal antibodies and antiviral agents as prophylaxis or to prevent severe infection from COVID-19 in NSW
- Consent Factsheet – Use of medicines for COVID-19 in NSW Health facilities (June 2022)
- Factsheet – Differing presentations of tocilizumab injections available for use in NSW Health facilities (Added 13 October 2021)
- Consensus Guideline – Remdesivir and nirmatrelvir plus ritonavir in renal impairment (December 2023)
- Drug Guideline – Use of baricitinib tablets for COVID-19 (Version 1.5, July 2022)
- Drug Guideline – Use of casirivimab and imdevimab injection for COVID-19 (Version 1.2, July 2022)
- Drug Guideline – Use of molnupiravir capsules for COVID-19 (Version 1.1, September 2022)
- Drug Guideline – Use of nirmatrelvir and ritonavir tablets for COVID-19 (Version 1.1, February 2022)
- Drug Guideline – Use of remdesivir injection for COVID-19 (Version 1.8.1, July 2022)
- Drug Guideline – Use of sarilumab injection for COVID-19 (Version 1.2, March 2022)
- Drug Guideline – Use of sotrovimab injection for COVID-19 (Version 1.4, March 2022)
- Drug Guideline – Use of tixagevimab and cilgavimab injection for COVID-19 (Version 1.3, February 2023)
- Drug Guideline – Use of tocilizumab injection for COVID-19 (Version 2.4, July 2022)
- Quick Guide – Preparation of casirivimab and imdevimab injection for administration via intravenous infusion (December 2021)
- Quick Guide – Preparation of casirivimab and imdevimab injection for administration via subcutaneous injection (December 2021)
- TGA Update on effectiveness of monoclonal antibodies against COVID variants (Link added 8 March 2023)
- Information for patients, family and carers – Baricitinib (Version 1, October 2021) [NSW TAG]
- Also available in Arabic, Assyrian, Hindi, Vietnamese and Chinese Simplified and Traditional
- Information for patients, family and carers – Casirivimab and imdevimab [Factsheet] (Version 1, December 2021)
- Information for patients, family and carers – Molnupiravir [Factsheet] (Version 1, February 2022)
- Information for patients, family and carers – Nirmatrelvir and ritonavir [Factsheet] (Version 1, February 2022)
- Information for patients, family and carers – Remdesivir [Factsheet] (Version 1.4, July 2022)
- Information for patients, family and carers – Sarilumab [Factsheet] (Version 1.1, March 2022)
- Information for patients, family and carers – Sotrovimab [Factsheet] (Version 1.3, March 2022)
- Information for patients, family and carers – Sotrovimab in Pregnancy [Factsheet] (Version 1.0, June 2022)
- Information for patients, family and carers – Tixagevimab and cilgavimab [Factsheet] (Version 1.2, February 2023)
- Information for patients, family and carers – Tocilizumab [Factsheet] (Version 1.5, March 2022)